The Absence of Human Equilibrative Nucleoside Transporter 1 Is Associated With Reduced Survival in Patients With Gemcitabine-Treated Pancreas Adenocarcinoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-04-0224
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)


Related search